TAVR Update

By Vivian G. Ng, MD

Current and Future TAVR Devices for Aortic Insufficiency

An outline of current experience with off-label TAVR for aortic insufficiency, as well as an overview of emerging dedicated TAVR devices for aortic insufficiency.

By Lauren S. Ranard, MD, and Torsten P. Vahl, MD

TAVR or SAVR First? A 62-Year-Old Man With Severe Aortic Stenosis

This hypothetical case scenario highlights necessary considerations regarding clinical and anatomic factors, long-term durability, and lifetime management when approaching decision-making in younger, lower-risk patients with severe aortic stenosis.

By Syed Zaid, MD, and Vinayak N. Bapat, MD, FRCS

Considerations When Treating Patients With Multivalvular Heart Disease

Diagnosis and management of the most common subtypes of mixed and multivalvular heart disease.

By Juan del Cid Fratti, MD, and Christine J. Chung, MD

The Continued Role of Transesophageal Echocardiography in TAVR: When a Minimalistic Approach Is Not Enough

A review of when transesophageal echocardiography may be preferred over transthoracic echocardiography and fluoroscopy during TAVR procedures.

By Vratika Agarwal, MD

Expert Outlook: What Are Your Main Concerns When Treating a Bicuspid Aortic Stenosis Patient With TAVR?

With Hasan Jilaihawi, MD, MRCP (UK), and Raj Makkar, MD, FACC

Embolic Protection During TAVR: Where Do We Go After PROTECTED TAVR?

Where we stand with data on cerebral embolic protection and a discussion of current and future devices for reducing the burden of stroke during TAVR.

By Amit N. Vora, MD, MPH; Yousif Ahmad, MD, PhD; and Alexandra Lansky, MD

Balloon Pulmonary Angioplasty in CTEPH and CTEPD: Where Is This All Going?

BPA is a promising therapeutic option for inoperable CTEPH, a highly disabling consequence of PE; however, randomized controlled trials are needed to assess its ultimate benefits.

By Riyaz Bashir, MD, FACC, RVT; William R. Auger, MD, FCCP; and Kenneth Rosenfield, MD, MHCDS

Study Uses The PERT Consortium Registry Data to Examine Practice Patterns and Outcomes in High-Risk Pulmonary Embolism

Study Evaluates Outcomes of Catheter-Based Therapy for Patients With Cancer and Intermediate- or High-Risk Pulmonary Embolism

Strain on Structural Heart: Staffing Reduction and Allocation Improves Access, Capacity

Insights from MedAxiom’s new CV business white paper highlight how the SH care delivery model can be optimized to better provide appropriate patient care and increase capacity.

By Ginger Biesbrock, DSc, PA-C, FACC

An Interview With Shrilla Banerjee, MD, FRCP, FESC

Dr. Banerjee discusses her interest in disparities in cardiovascular care, involvement in organizations seeking to address equity concerns within the interventional cardiology field, best practices for calcium modification and MINOCA, and more.